跟读练习: A pediatric cerebrovascular approach: techniques and challenges - 通过YouTube学习英语口语
C2
Music My
138 句
如果句子过短或过长，请点击 Edit 进行调整。
1
Music My
2
practice is unique in the fact that I do about 90 percent,
3
85 percent of what I do is all children.
4
children with vascular malformations, both of the brain and the neck, maxillofacial areas.
5
We receive them from newborn actually to 19, 18 years of age.
6
We do of course also adults with vascular malformations,
7
but as things are evolving and you can see how fantastic this course is and the tremendous progress that has exist.
8
So children are not small adults and that has happened throughout medicine.
9
There was the general doctor first,
10
then became pediatricians, which was obviously that required different things.
11
So within the vascular lesions of the human body,
12
there's a certain amount of diseases that occur in children primarily,
13
and that affect children sometimes exclusively.
14
So, based on my practice,
15
I have dedicated myself to improve the treatment in those children,
16
decrease the radiation, decrease the time of the procedure,
17
being very meticulous with the technique, very meticulous with fluids.
18
For small children that are in severe heart problems with brain problems,
19
if you use the same techniques in adults,
20
you actually could have a lot of harm.
21
So there are dedicated, specific problems that occur in children.
22
There are specific, dedicated challenges,
23
technical, medical, physiological, that are specific for children.
24
And there's even difference between children and newborns.
25
We have newborns that are born in severe heart failure with a disease called vein of gallant malformation
26
that even treated is lethal within the first year of life.
27
So those children require techniques,
28
for example, we develop techniques to go through the umbilical artery.
29
So we can actually place a cathode from the umbilical artery to enter the body,
30
to then navigate into the brain.
31
In this pediatric population, the diseases are rare,
32
so it's very hard to do really trials.
33
We're more involved in developing devices,
34
actually because coming from children,
35
they can be translated towards adults.
36
We also have a lot of patients,
37
or practices, patients of rare diseases,
38
such as vascular malformation of the maxillofacial area.
39
very difficult to treat.
40
So we have developed techniques like direct percutaneous puncture.
41
Instead of going from the femoral artery and trying to catheterize them,
42
it's to actually use 3D angiography or the eye guide
43
or the different types of technologies that have been developed for adults
44
and try to use them to place catheters or needles directly into the malformation.
45
And that has changed the whole ballgame.
46
We also involve trying to develop things which are called sclerotherapy.
47
Sclerotherapy is a technique in which you inject something that will damage the endothelium.
48
And then the healing of that scarring,
49
that will produce scarring, will actually sclerose or thrombose or close and scar those vascular malformations that they cannot feel.
50
And that includes venous malformation.
51
That includes lymphatic malformations.
52
That includes arteriovenous malformation.
53
And we're using biological substances such as chemotherapeutic agents, bleomycin for example.
54
And they've made a tremendous change in the outcome of this patient.
55
Actually, we're trying to use more and more ultrasound to guide ourselves to do these procedures.
56
Also, within the medical industry of x-rays,
57
we're forcing the manufacturers to create things like last image hold.
58
And then with that last image hold,
59
will, for example, collimate, try to center memories so that we don't have to radiate these children.
60
Mothers come to me and ask me that,
61
will my child have a stroke while you're doing this horrible malformation?
62
They ask me how much radiation are they gonna get?
63
Or the anesthesia?
64
Well, there is a potential role for endovascular radiosurgery.
65
I worked like 15, 20 years ago to try to treat vascular malformations that way.
66
But radiation is a difficult thing to control.
67
It's a difficult thing to prove,
68
a difficult thing to get approved through a regulatory pathway like the Food and Drug Administration and so on.
69
And dangerous for everyone, including you as an operator.
70
Everything is dangerous if it's improperly used.
71
You know, if you have a genie and you let the genie out of the box and there's no control,
72
it can be very, very dangerous.
73
So I would say that radiation has a potential,
74
but it is not something that is around the corner.
75
The tools that we have today are pretty much adaptation of adults to children.
76
So we're still at the beginning.
77
We're very much interested in developing tools that are designed for newborns and for children,
78
which today do not exist.
79
So we take a catheter that is a meter and a half,
80
because it's the only catheter that we have.
81
The technology exists, but the market is so small
82
that industry is not very interested in developing high technology for a very small market.
83
And this is not simply the question of smaller arteries.
84
It's a whole question of a different anatomy that you're dealing with.
85
It's a different anatomy.
86
It's a different technology necessary for the stiffness, for example.
87
You know, the blood vessels in children are more fragile in a sense.
88
But on the other hand, they're more elastic.
89
So they have their own specific problems,
90
both technically as well as physiological.
91
One of the biggest questions that we have is if we take a device,
92
for example a stent, that is developed for adults which have stopped growing and we put them in small children,
93
what would happen to those vessels as we increase in size?
94
And therefore, personally, we have a lot of skepticism of using stents unless we are really forced.
95
And the other side of the coin is we're going to press
96
and push industry to develop bioactive or biodegradable devices so that
97
if I put a stent in a little child and that stent will then be reabsorbed,
98
it will permit then the normal physiologic growth.
99
Biodegradable, bioabsorbable, biocompatible.
100
It's one of the great, great, great potential expansion.
101
If we can develop it for children,
102
it can then be transferred to adults.
103
What is interesting is that we've done very small devices based on trying to do it for pediatrics,
104
and those have translated to go to the adult,
105
which permits you to go to more distal circulation.
106
I think that's very valuable for the training of physicians.
107
You know, when I started,
108
it was see one, do one,
109
teach one, that no longer applies.
110
We're not, it's just so much better to train,
111
and I'm very involved in the training of physicians,
112
training physicians in a in vitro model.
113
You know, get all, I mean,
114
you actually today, the reproduction is, Dr. Moret, so fantastic.
115
You know, it's literally like the real thing.
116
But then you get the physician to learn.
117
You get the physician to train,
118
you get the physician to try,
119
you get the physician to make the mistake in a model.
120
By the time you transfer that to the real patient,
121
you have a much better trained physician.
122
And I think industry is now more and more turning to these models.
123
And the regulatory agencies are saying,
124
wait a second, you not only have to go and train in a model first.
125
You know, it used to be sometimes an animal.
126
Then, you know, as you know,
127
there's a lot of movement against training in animals.
128
So these things have replaced a lot of the training.
129
The regulatory agencies will force us to train physicians in this type of models that are now readily available.
130
3D printing can make exactly the same aneurysm immediately, right away.
131
And not only that, I can make 20 of those,
132
or 50, or 100 to train physicians.
133
So that I do believe that following that comes the proctoring.
134
In other words, now you're going to go,
135
this individual who's trained in the model is going to go do humans.
136
So when you go humans,
137
you go with somebody experience,
138
the fracture you, I think that is absolutely the way to go.
下载应用
AI 为你说出的每个句子打分
TRENDING
热门
背景与介绍
在这段视频中，讲者分享了他们在儿科介入医学方面的独特实践，尤其是针对儿童的血管畸形。这些专业技术和经验不仅限于治疗老年人，临床实践中遇到的挑战也因儿童的生理特征而显得格外复杂。讲者强调，儿童在医学上并不是小型成人，他们面临不同于成人的医疗问题和技术挑战。因此，针对儿童的医疗技术需要很高的精密度和针对性，尤其是在涉及重要器官如大脑的治疗过程中。
日常交流的五个关键短语
- 小儿血管畸形 - 指儿童体内的血管异常情况。
- 技术挑战 - 进行特定医学程序过程中遇到的困难。
- 微创技术 - 一种能够减少手术创伤、提高手术成功率的医疗方法。
- 内皮损伤 - 指影响血管内层的治疗过程。
- 直接穿刺技术 - 一种通过皮肤直接到达目标区域的医疗技术。
逐步影子跟读指南
为了提高您的英语口语能力和跟读技巧，您可以遵循以下步骤，利用视频内容进行学习：
- 选择合适的段落：从视频中选择一个涵盖医学术语的段落，以帮助您熟悉这类专业语言。
- 播放视频并暂停：收听讲话并暂停每个句子，确保您能够准确听清讲者的发音和语调。
- 模仿发音：对照视频中的内容，大声重复讲者说的每一句话。这是提升您的英语口语练习和发音的重要步骤。
- 注意语调与重音：理解并模仿句子的语调与重音，例如在关键术语（如“小儿血管畸形”）上加强语音，帮助您掌握医学专业英语。
- 反复练习：定期进行这种英语影子跟读练习，可以帮助您在口语表达中更加自信，特别是准备雅思口语练习时。
通过这种逐步影子跟读的方法，您可以有效地提升在不同场景下的英语口语能力，特别是在与医学相关的交流中，使自己在专业术语的使用上更加流畅。为了获取更多学习资源，欢迎访问相关的shadowing site，开启您的英语学习之旅！
什么是跟读法？
跟读法 (Shadowing) 是一种有科学依据的语言学习技巧，最初开发用于专业口译员的培训，并由多语言者Alexander Arguelles博士普及。这个方法简单而强大：您在听英语母语原声的同时立即大声重复——就像是一个延迟1-2秒紧跟说话者的影子。与被动听力或语法练习不同，跟读法强迫您的大脑和口腔肌肉同时处理并模仿真实的讲话模式。研究表明它能显着提高发音准确性，语调，节奏，连读，听力理解和口语流利度——使其成为雅思口语备考和真实英语交流最有效的方法之一。